当前位置:首页 - 行情中心 - 万邦医药(301520) - 财务分析 - 资产负债表

万邦医药

(301520)

  

流通市值:9.64亿  总市值:28.66亿
流通股本:2242.30万   总股本:6666.67万

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金151,823,897.33179,294,435.57173,284,439.23175,323,414.01
结算备付金00--
拆出资金00--
衍生金融资产00--
应收票据及应收账款77,574,171.2675,904,327.2982,876,652.1466,725,035.15
其中:应收票据9,829,689.5712,012,254.9213,245,445.639,390,935.98
应收账款67,744,481.6963,892,072.3769,631,206.5157,334,099.17
应收款项融资00--
预付款项10,840,590.779,942,873.5510,410,522.9510,847,125.57
应收保费00--
应收分保账款00--
应收分保合同准备金00--
其他应收款合计7,254,026.283,990,203.954,586,966.873,789,828.58
其中:应收利息00--
应收股利00--
买入返售金融资产00--
存货736,765.051,960,203.84840,279.681,022,292.34
合同资产111,011,954.21100,578,246.8294,397,398.5393,246,661.61
一年内到期的非流动资产00--
其他流动资产8,069,095.927,596,175.4760,006,274.5659,088,852.9
流动资产平衡项目0000
流动资产合计1,373,385,553.451,402,736,641.421,394,558,447.31,373,171,254.81
非流动资产:
发放委托贷款及垫款00--
债权投资00--
其他债权投资00--
长期应收款00--
长期股权投资00--
其他权益工具投资00--
其他非流动金融资产3,000,0003,000,000--
投资性房地产6,887,191.46,985,054.617,082,917.827,180,781.03
固定资产172,032,190.09174,767,718.24177,272,635.61167,267,355.24
在建工程6,475,740.711,665,843.83--
生产性生物资产00--
油气资产00--
使用权资产00--
无形资产11,394,853.4111,572,652.4115,237,571.8911,438,770.88
开发支出00-4,282,396.15
商誉00--
长期待摊费用2,302,372.822,746,119.174,254,534.024,542,554.69
递延所得税资产249,397.590200,290.53269,948.15
其他非流动资产476,761.23333,984.381,237,147.792,991,812.68
非流动资产平衡项目0000
非流动资产合计202,818,507.25201,071,372.64205,285,097.66197,973,618.82
资产平衡项目0000
资产总计1,576,204,060.71,603,808,014.061,599,843,544.961,571,144,873.63
流动负债:
短期借款00--
向中央银行借款00--
吸收存款及同业存放00--
拆入资金00--
交易性金融负债00--
衍生金融负债00--
应付票据及应付账款39,620,377.3437,833,222.0638,617,305.3632,497,872.91
其中:应付票据00--
应付账款39,620,377.3437,833,222.0638,617,305.3632,497,872.91
预收款项00--
合同负债15,068,353.1719,699,559.1315,588,512.0918,072,085.26
卖出回购金融资产款00--
应付手续费及佣金00--
应付职工薪酬5,117,491.5413,330,686.8514,356,500.1210,228,303.99
应交税费577,122.371,007,038.471,292,481.643,026,754.06
其他应付款合计1,830,823.061,884,736.181,128,877.042,691,400.12
其中:应付利息00--
应付股利00--
应付分保账款00--
保险合同准备金00--
代理买卖证券款00--
代理承销证券款00--
一年内到期的非流动负债00--
其他流动负债882,100.89960,710.18906,410.42994,881.92
流动负债平衡项目0000
流动负债合计63,096,268.3774,715,952.8771,890,086.6767,511,298.26
非流动负债:
长期借款00--
应付债券00--
优先股00--
永续债00--
租赁负债00--
长期应付款00--
长期应付职工薪酬00--
预计负债00--
递延收益7,115,148.737,413,327.017,876,516.238,119,690.91
递延所得税负债8,371,304.418,310,227.5811,603,037.249,804,503.28
其他非流动负债00--
非流动负债平衡项目0000
非流动负债合计15,486,453.1415,723,554.5919,479,553.4717,924,194.19
负债平衡项目0000
负债合计78,582,721.5190,439,507.4691,369,640.1485,435,492.45
所有者权益(或股东权益):
实收资本(或股本)66,666,66766,666,66766,666,66766,666,667
其他权益工具00--
优先股00--
永续债00--
资本公积1,037,419,668.531,037,419,668.531,037,419,668.531,037,419,668.53
减:库存股7,740,6242,838,596--
其他综合收益00--
专项储备00--
盈余公积40,578,122.0940,526,803.3833,073,818.6133,073,818.61
一般风险准备00--
未分配利润360,697,505.57371,593,963.69371,313,750.68348,549,227.04
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计1,497,621,339.191,513,368,506.61,508,473,904.821,485,709,381.18
少数股东权益00--
股东权益平衡项目0000
股东权益合计1,497,621,339.191,513,368,506.61,508,473,904.821,485,709,381.18
负债和股东权益合计1,576,204,060.71,603,808,014.061,599,843,544.961,571,144,873.63
公告日期2025-04-222025-04-222024-10-252024-08-23
审计意见(境内)标准无保留意见
TOP↑